Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Imdex (IMD.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-02-28	2.69	3.10	Neutral
2022-07-22	1.81	-	No Rating
2022-07-29	1.81	3.10	Neutral
2022-08-16	1.93	2.20	Neutral
2022-10-24	2.04	2.28	Neutral
2023-01-19	2.47	2.50	Neutral
2023-02-14	2.43	2.75	Neutral
2023-06-16	1.90	2.10	Neutral
2023-08-29	1.61	2.10	Buy
2024-02-20	2.01	2.25	Buy
2024-05-07	2.00	2.20	Buy
2024-08-22	2.08	2.35	Buy
2024-11-23	2.57	-	No Rating
2024-12-02	2.51	2.60	Neutral
2025-02-12	2.85	2.95	Neutral
2025-04-28	2.75	3.00	Neutral
2025-05-06	2.81	2.90	Neutral

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.